Journal List > Nutr Res Pract > v.3(1) > 1051009

Nutr Res Pract. 2009 Spring;3(1):15-22. English.
Published online March 31, 2009.  https://doi.org/10.4162/nrp.2009.3.1.15
©2009 The Korean Nutrition Society and The Korean Society of Community Nutrition
Effect of Chlorella intake on Cadmium metabolism in rats
Jee Ae Shim, Young Ae Son, Ji Min Park and Mi Kyung Kim
Department of Nutritional Science and Food Management, Ewha Womans University, 11-1 Daehyun-dong, Seodaemun-gu, Seoul 120-750, Korea.

Corresponding Author: Mi Kyung Kim, Tel. 82-2-3277-3092, Fax. 82-2-3277-2862, Email: mkk@ewha.ac.kr
Received December 07, 2008; Revised January 20, 2009; Accepted February 05, 2009.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


Abstract

This study was performed to investigate the effect of chlorella on cadmium (Cd) toxicity in Cd- administered rats. Sixty male Sprague-Dawley rats (14 week-old) were blocked into 6 groups. Cadmium chloride was given at levels of 0 or 325 mg (Cd: 0, 160 ppm), and chlorella powder at levels of 0, 3 and 5%. Cadmium was accumulated in blood and tissues (liver, kidney and small intestine) in the Cd-exposed groups, while the accumulation of Cd was decreased in the Cd-exposed chlorella groups. Fecal and urinary Cd excretions were remarkably increased in Cd-exposed chlorella groups. Thus, cadmium retention ratio and absorption rate were decreased in the Cd exposed chlorella groups. Urinary and serum creatinine, and creatinine clearance were not changed in experimental animals. In addition, metallothionein (MT) synthesis in tissues was increased by Cd administration. The Cd-exposed chlorella groups indicated lower MT concentration compared to the Cd-exposed groups. Moreover, glomerular filtration rate (GFR) was not changed by dietary chlorella and Cd administration. According to the results above, this study could suggest that Cd toxicity can be alleviated by increasing Cd excretion through feces. Therefore, when exposed to Cd, chlorella is an appropriate source which counteracts heavy metal poisoning, to decrease the damage of tissues by decreasing cadmium absorption.

Keywords: Chlorella; cadmium; excretion; heavy metal; metallothionein (MT)

Introduction

Cadmium (Cd) is one of the heavy metals and existing very low levels in nature (Chapman et al., 2003). However, it is very toxic and an important environmental pollutant in soil, water, air, food and smoke (Järup et al., 1998). Cadmium is mainly used in the industry for coating steel, glass and plastics (including polyvinyl chloride), and for nickel cadmium battery production (Tsalev & Zaprianov, 1993). It has a very long biological half-life (10-30 years) in human body and its toxicity is dependent on the route, amount and the duration of exposure (Goering et al., 1987; Goyer & Cherian, 1995; Satarug et al., 2003). The chronic Cd exposure in human appears to result in nephrotoxicity and osteoporosis, pulmonary emphysema, liver dysfunction, etceteras (Berglund et al., 2000; Goyer & Cherian, 1995; Rikans & Yamano, 2000; Shaikh et al., 1999). When cadmium is taken into the body, it is slowly excreted after combining with proteins like albumin and metallothionein (MT), or negative ions of other molecules, especially the -SH group, without the process of metabolism like oxidation, reduction, and alkylation. Also, it is severely toxic in cases of both acute and chronic intoxications; your liver and testis become the target organs during acute intoxication, while your kidney becomes the target organ when chronic Cd intoxication happens (Brzóska et al., 2003; Casalino et al., 2002).

Metallothionein (MT) has the molecular weight of 6,000~7,000 and does not contain aromatic amino acids and histidine, and it is a low molecular weight protein abundant in cysteine (33%) (Kägi & Schäffer, 1988; Manuel et al., 1992). Metallothionein has 7 metal binding sites, so it can control the metabolism of several metal ions and mitigates toxicity of heavy metals. It also relates to the immune reaction and prevents tissue damage caused by heavy metal (Nordberg, 1992). The MT synthesis is known to be induced by several metal ions and hormones, stress and cytokine (Hidalgo et al., 1990). There is a report that MT subsists in a very low density under normal circumstances, but the MT amount grows when the synthesis is promoted by metals like Cd or Pb in organs such as liver (Nordberg & Nordberg, 1987). MT can be synthesized anywhere inside the body but mostly in the liver and kidney, and can be combined with Cd, which prevents free reactive Cd from making to the body which makes toxic materials (Cousins et al., 1973). The half-life of MT differs to the metal it combines with, but is rather short from 1 to 4 days, so the MT must be combined endlessly to counteract poison made by Cd or heavy metals (Revis & Osborne, 1984). The study about Cd and MT synthesis and Cd's removal system through MT has been developed profoundly because Cd's affinity with MT is high compared to other metal ions. As seen above, the study about the prevention and the treatment of Cd-intoxication is becoming a field of interest. While the study about the dietary factor which affects absorption of Cd into the body is drawing attention, there is a report that protein, calcium, and fiber reduce the absorption of Cd and the accumulation to the liver and kidney (Omori & Muto, 1977; Revis & Osborne, 1984).

In addition, chlorella has been demonstrated to develop tolerance to Cd polluted environment (Morita et al., 1999). Chlorella is a unicellular green algae that reproduces at a rapid rate. It has been known to contain highly nutritious substances and to exert various biological effects (Kojima et al., 1973). Chlorella contains about 55~67% protein, 1~4% chlorophyll, 9~18% dietary fiber and an amount of minerals and vitamins (Morita et al., 1999). Also, it contains all the essential amino acids required for the nutrition of animals and humans. This algae is considered to be highly resistant to heavy metals such as Cd. The algae can chelate heavy-metal ions such as Cd (Yoshida et al., 2006). Recently, chlorella has been used as a health food or functional food in Japan, the U.S. and other countries (Morita et al., 1999).

In order to use chlorella as a tool for Cd-removal and recovery, it is necessary to characterize its metal-tolerance and metal- binding capacity. Numerous studies have shown that chlorella intake may reduce Cd absorption and accumulation, and also prevent or reduce the adverse actions of Cd (Han et al., 2002; Hwang et al., 2006a; Hwang et al., 2006b; Morita et al., 1999). The aim of our study was to investigate the possible Cd-removal by chlorella intake on Cd metabolism. We measured Cd concentrations (blood, urine, liver, kidney, small intestine and feces), metallothionein (liver, kidney, small intestine) and kidney capacity.

Materials and Methods

Experimental material

The chlorella powder (chlorella vulgaris) used in this study was manufactured by Daesang Co. (Korea) and the characteristics of chlorella powder is shown in Table 1.


Table 1
Specifications of chlorella powder extract
Click for larger image

Animal care and dietary treatment

Sixty 14-week-old male Sprague-Dawley rats (CD (SD)IGS, Outbred, Charles River Laboratory Inc. Origin; Jung-Ang Lab Animal, Inc., Korea) weighing 399.06 ± 0.8 g were blocked into 6 groups according to body weight and raised for 10 weeks on experimental diets. Two-factorial nested classification design, which is shown in Table 2, was used. The independent variables were dietary Cd level and chlorella level. Animals were placed in individual stainless steel wire-mesh cages in an automatically controlled room. All instruments were treated with 0.4% ethylene diamine tetraacetic acid (EDTA) solution, 10% nitric acid solution and then washed with distilled water to avoid other mineral contaminations. The composition of the experimental diets is shown in Table 3. The chlorella powder (Chlorella vulgaris) used in this study was manufactured by Daesang Co. (Korea). The diets were mixed according to the AIN-93G diet (Reeves et al., 1993) with slight modifications. Corn starch (Daesang Co., Korea) was the only source of carbohydrate in the mixture. Casein (Murray Goulburn Co., Australia) was used as a source of protein and soybean oil (CJ Co., Korea) was used as a source of lipid. Mineral and vitamin mixtures were purchased from Dyets Inc. (U.S.A). Also, Cd chloride (CdCl2) was substituted for cornstarch and animals were provided with 0.325 g CdCl2 per kg diet. The 0% chlorella diet contained no chlorella in the diet and the 3% chlorella diet contained 3% chlorella per kg diet. The 5% chlorella diet contained 5% chlorella per kg diet. This study was conducted at the nutrition laboratory of Ewha Womans University, in compliance with the Guide for the Care and Use of Laboratory Animals. During the experimental period, the rats were allowed free access to the experimental diets and de-ionized water. Body weight was recorded weekly. Food intake was recorded three times per week.


Table 2
Classification of experimental groups
Click for larger image


Table 3
Composition of experimental diets (g/kg diet)
Click for larger image

Specimen Collection

To gauge Cd retention ratio, Cd tube feeding was inserted of 0.2 ml CdCl2 solution (CdCl2 325 ppm (Cd 160 ppm)) daily for the final 2 weeks before the end of the experimental period. The rats were not provided with cadmium diet for the tube feeding period and considering the stress from tube feeding, Cd-free groups had 0.2 ml de-ionized water tube feeding. Feces and urine were collected using the metabolic cages for the final 2 days before the end of the experimental period. Feces were weighed and stored at -80℃ until analysis. Urine was collected in a bottle treated with a few drops of 0.1% HCl and toluene as embalmments. After collection, the bottle was filled up to 100 ml with de-ionized water and centrifuged at 7,000 rpm for 10 minutes (Supra 22K high speed centrifuge, Hanil, Korea). Aliquots of the samples were stored at -80℃ until analysis. At the end of the experimental period, the animals were plundered of food for 12 hr and sacrificed after anesthetization with ethyl ether. After blood samples were collected directly from the heart with a heparinized or non-treated syringe, whole blood samples collected with heparin-treated syringes were transferred to polypropylene tubes, which were frozen at -80℃ in a deep freezer until analysis for cadmium concentration. Blood samples collected using non-treated syringes were placed in an ice bath for 20 minutes and then centrifuged at 2,800 rpm for 30 minutes at 4℃ (Union 55R centrifuge, Hanil, Korea). Obtained serum was for measuring the levels of AST and ALT. The liver, kidney, spleen, epididymal fat pad, perirenal fat pad and femur were removed and weighed. They were cut into small pieces, frozen over dry-ice and stored at -80℃ in a deep freezer until analysis.

AST and ALT

Serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) activities were measured using a kit (Asan Pharmaceutical, Korea) based on the Reitman-Frankel method (Reitman & Frankel, 1957).

Cadmium concentration in blood and urine

Blood and urine cadmium levels were measured from the method of Zinterhofer (1971). These were determined using an atomic absorption spectrophotometer (AAS, Model 6701F, SHIMADU Co., Japan). The analyses were performed at the 228.8 nm resonance line.

Cadmium concentration in small intestine, liver, kidney and feces

Cd concentrations were measured from the samples using the method of Yeager (1971). These were determined using an atomic absorption spectrophotometer (AAS, Model 6701F, SHIMADU Co., Japan).

Determination of Metallothionein in small intestine, liver and kidney

Metallothionein (MT) concentration was measured from the method of cadmium/hemoglobin affinity assay (Eaton & Cherian, 1991; Eaton & Toal, 1982; Onosaka & Cherian, 1982). The rat red blood cell (RBC) hemolysate was used from the method of Onosaka and Cherian (Yeager et al., 1971). The concentration of MT in each tissue was calculated by assuming that 7 g-atom of Cd is bound to each mole of thionein which has a molecular weight of 6050 by amino acid analysis (Kagi & Nordberg, 1979).

Cadmium retention

The rates were calculated using the cadmium absorption rate and retention ratio.

Creatinine clearance

Urinary and serum creatinine were measured using a kit (IVDLAb CO., LTD, Korea) based on Jaff's reaction (Owen, 1954; Simoni et al., 2002). Absorbance at 505 nm was determined using a spectrophotometer (Genesys 10 UV, Thermo Electron Co., USA). All procedures followed the manufacturers' instructions. These were calculated using creatinine clearance (glomerular filtration rate, GFR, ml/min).

Statistical analysis

All results were expressed as means ± standard error (SE). The one-way analysis of variance (ANOVA) and mean differences among the experimental groups were evaluated by Duncan's multiple range tests at the p<0.05 level.

Results

Effect of dietary cadmium and chlorella on daily food intake, calorie intake, food efficiency ratio in rats

Daily food intake, body weight gain during the experimental period and food efficiency consumed are shown in Table 4. Daily food intake, body weight gain and food efficiency consumed were significantly influenced by the Cd level. The animals fed Cd administration diets had significantly lower levels of these indexes than animals fed other diets. As shown in Table 4, food intake was slightly decreased in chlorella intake groups compared with that of 0% chlorella group, and these alterations were shown in both Cd-exposed and Cd-free groups. But, food efficiency consumed was slightly increased in chlorella intake groups compared with that of the 0% chlorella group, especially the 5% chlorella diet in Cd-exposed group.


Table 4
Food intake, calorie intake, weight gain and food efficiency ratio in rats fed diets containing chlorella powder
Click for larger image

The weight of liver, kidney and femur

The weight of the liver, kidney and femur are shown in Table 5. In comparison among the chlorella groups, there was no significant difference in all these organ weights. The weights of the liver and kidney were lowest in rats fed the Cd diet. However, these did not show differences among the chlorella groups. Also, femur weight had no significant difference in rats fed both Cd and chlorella diet.


Table 5
The weight of liver, kidney and femur in rats fed diets containing chlorella powder
Click for larger image

Serum AST and ALT activities

Serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) activities are shown in Table 6. The ranges of serum AST and ALT activities were 50.57~60.43 IU/L and 20.19~28.91 IU/L, respectively. These levels were included within the reference range (AST: 39~262 IU/L, ALT: 20~60 IU/L) in Sprague-Dawley rats (Reitman & Frankel, 1957). Therefore all diets were considered to be nontoxic for liver function.


Table 6
Serum AST and ALT activities of rats fed diets according to different Cd levels and dietary chlorella levels (Unit: IU/L)
Click for larger image

Cadmium concentrations in small intestine, blood, liver and kidney

Cadmium concentrations in small intestine, blood, liver and kidney are shown in Table 7. Cadmium concentrations in blood and organ tissues were significantly affected by Cd administration and dietary chlorella level. Cadmium concentrations in the blood and organ tissues of Cd-exposed groups were significantly higher than those of Cd-free groups. However, chlorella intake significantly decreased Cd concentrations in the blood and kidney, especially animals fed 5% chlorella diet.


Table 7
Cadmium concentrations in small intestine, blood, liver, and kidney
Click for larger image

Metallothionein in small intestine, liver and kidney

Metallothionein, consisted with cysteine, exists at a very low concentration in general environment (Manuel et al., 1992; Revis & Osborne, 1984; Tsuritani et al., 1992). Metallothionein concentrations in small intestine, liver and kidney are shown in Table 8. Hepatic MT concentration was markedly increased by Cd administration compared with that of control groups. Specially, this study reveals that MT concentration is significantly decreased with chlorella treatment in Cd-exposed groups. In addition, renal MT concentration in Cd-exposed groups was elevated. Moreover, MT concentration in small intestine was higher in Cd-exposed groups than Cd-free groups. When animals were administered cadmium, MT concentration in kidney was remarkably lower in the 5% chlorella group than the 0% chlorella group. These significantly decreased dietary chlorella in a dose-dependent manner. There was a relationship between Cd-administration and dietary chlorella level in the liver, kidney and small intestine.


Table 8
Metallothionein concentrations in small intestine, liver and kidney
Click for larger image

Urinary and fecal cadmium excretions, Cadmium retention ratio and Cadmium absorption rate

The results of cadmium excretions in urine and feces that were collected during the administration of cadmium through tube feeding and the cadmium retention ratio were showed in Table 9. Urinary and fecal cadmium excretions of Cd-exposed animals were remarkably higher than those of Cd-free animals. However, these were decreased with increasing dietary chlorella levels, particularly animals fed 5% chlorella diet in urinary cadmium excretion. Moreover, Cd excretions in urine and feces were affected by the interaction between dietary chlorella level and Cd level.


Table 9
Urinary and fecal cadmium excretions, Cadmium retention ratio and absorption rate
Click for larger image

The calculated Cd retention ratio using urinary and fecal Cd excretions was significantly affected by dietary chlorella levels. Namely, Cd retention ratio of rats fed 3% chlorella diet and Cd had the lowest among Cd-exposed groups. But, there was no significant difference among Cd-free groups. In addition, calculated Cd absorption rate using fecal cadmium excretions similarly indicated the results of Cd retention ratio.

Renal creatinine clearance

To estimate abnormalities of renal function by Cd toxicity, creatinine clearance was calculated from serum creatinine concentration and urinary creatinine excretion. As shown in Table 10, serum and urinary creatinine, and creatinine clearance were not changed in experimental animals.


Table 10
Urinary creatinine excretions, serum creatinine concentration and creatinine clearance
Click for larger image

Discussion

This study investigated the effect of exposure to Cd and the influence of chlorella intake on Cd administration. Small intestinal absorption of Cd is characterized by high accumulation within the intestinal mucosa and metal-binding proteins were induced in the presence of Cd. Cd-MT form is excreted into the feces with a cell turnover at the same time (Elsenhans et al., 1997). After Cd is absorbed from the small intestine into blood plasma, Cd is mainly taken up into the liver. The Cd-albumin is moved to the liver and Cd-MT form is moved to the kidney (Wang et al., 1993). Chronic Cd exposure can cause renal proximal tubular dysfunction resulting from the release of liver Cd-MT and its accumulation and degradation in the renal tubular epithelial cells (Friberg et al., 1974). Therefore, renal Cd is made up of free ion form. The reason for this redistribution of Cd has been shown to be its binding to MT that it is readily filtered through the glomerular membrane and is obtained selectively in the renal tubules (Nordberg et al., 1975). Moreover, Cd ion induces new renal MT synthesis (Dorian et al., 1992). When much amount of Cd-MT existed in the kidney, Cd-MT in blood was excreted into urine (Friberg, 1984). A damage of the proximal renal tubular cells increases urinary Cd excretion with low molecular weight proteins. Also, Cd increases bone Ca resorption and is accumulated in bone matrix instead of Ca. From the above explanation, Cd affects bone matrix formation and mineralization. Thus, it inhibits growth and maturation of bone tissue. (Wilson et al., 1996) During the experimental period, a decrease in body weight was noted in Cd-exposed groups. Consistent with these results, another study (Jemai et al., 2007) showed that body weight gain in the Cd-exposed rats was decreased significantly. Also, in numerous other studies (Cousins et al., 1973; Toraason & Foulkes, 1984), food intake and food efficiency were significantly depressed in Cd-exposed groups compared to Cd-free groups. In this study, food efficiency was influenced by 5% chlorella diet compared with 0% chlorella diet in rats administered Cd. Chlorella contains CGF (chlorella growth factor) which is water soluble S-nucleotide adenosyl peptide complex and a factor of rejuvenescence. In addition, it helps growth promotion of animal and plant, increase of immune system and improvement of apoplexy (Han et al., 2002). Thus chlorella might prevent growth inhibition of Cd because of CGF (chlorella growth factor) which is contained in chlorella. In our study, weight of the liver and kidney, which have been known to be responsible for Cd removal (Toraason & Foulkes, 1984) were decreased by Cd administration, however, these were not influenced by dietary chlorella level. The results of our experiments could be shown in tissue damage or decrease of body weight by Cd-administration, but that were not affected by chlorella groups. In addition, the weight of femur was not influenced by Cd and dietary chlorella. Femur was affected by exposure to Cd in a dose- and duration-dependent manner (Brzóska et al., 2005). Finally, rats fed 160 ppm Cd for 10 weeks did not induce intoxication in this study, where Cd concentration in small intestine was decreased in Cd- exposed chlorella groups. Also, fecal Cd excretion was remarkably increased in Cd-exposed chlorella groups compared to the Cd-free groups but there was no difference among the chlorella groups. Dietary fibers contained in chlorella cells may inhibit Cd absorption from the digestive tract by promoting its excretion into feces (Singh et al., 1999). Dietary fiber could trap Cd within the epithelial cells of the intestine and eventually excreted via feces with the esquamating cells (Andersen et al., 1992; Valberg et al., 1976). In addition, intestinal Cd and MT concentrations were lower than the liver and kidney by chlorella in this study. The other study reported that after rats were pretreated with Zn, animals once injected Cd. The result showed that intestinal Cd concentration was elevated after 4 h. but intestinal Cd concentration was decreased within 16~24 h. In consequence, the Cd-MT form in the small intestine was excreted into lumen after sequestering with intestinal lumen cell (Min et al., 1991). Considering these facts, the chlorella diet had the effect of Cd-removal by the inhibition of intestinal Cd absorption, due to dietary fiber contained in chlorella. Therefore, the Cd absorption rate and Cd retention ratio were decreased in chlorella diet groups. Cadmium concentrations of liver and kidney were increased in Cd-exposed groups compared to Cd-free groups in this study. In addition, the exposure to Cd increased its concentration in the blood. However, Cd concentrations in liver, kidney and blood were decreased in Cd-exposed chlorella groups. Hwang et al. (2006a) showed that hepatic and renal Cd concentrations were significantly decreased in chlorella supplementation groups. Thus, it was speculated that chlorella intake decreased Cd concentrations in liver, kidney and blood. In mammals, most of the total body burden of Cd is associated with MT. One molecule of MT can bind with 7 atoms of Zn or Cd. Metallothinein has been proposed to play important roles in the removal of heavy metals such as Cd and in the scavenging of oxygen-free radicals (Goering et al., 1995; Sato & Bremner, 1993). Cadmium in the cell is classified into two forms; MT-bound form and non-MT-bound form. Also, several studies reported that the MT-bound form is not toxic. However, the non-MT-bound form is having toxicity (Manuel et al., 1992; Nordberg, 1984). A non-MT bound form is produced when MT is not synthesized yet or when Cd, more than the inducible MT amounts, is inserted. Therefore, Cd concentrations in tissues did not reflect in all Cd toxicity. Shim et al., showed that hepatic MT II was more expressed in the Cd-5C and Cd-10C groups than in the Cd-0C group (Shim et al., 2008). In other words, Cd concentration is associated with MT synthesis. In fact, the basal MT level in the liver and kidney plays an important role in removal of Cd toxicity. The amount of synthesized MT in the liver and kidney of Cd-administered groups was significantly higher than those of Cd-free groups in this study. Absorbed Cd in human body induced MT synthesis in accordance with Cd dosage and duration of Cd feeding (Park et al., 1994). Other studies showed that MT synthesis was increased in proportion to Cd accumulation in the body (Goering & Klaassen, 1984; Hwang et al., 2006b). Furthermore, it has been reported that Cd induces the upregulation of cytoprotective and metal-scavenging proteins such as MT (Thevenod, 2003; Thijssen et al., 2007). In addition, newly synthesized MT was not induced by chlorella intake in this study. Conversely, the chlorella diet was not effective in increasing the basal MT level when the Cd was taken up. Also, in the other study, 46 male SD rats were given dietary supplementation with 1%, 5%, and 10% dried chlorella and 40 ppm of Cd for 4 weeks. The result showed that total MT synthesis in the liver and kidney was lower in the group of rats on the supplementation with chlorella and 40 ppm of Cd than the control group of rats on the supplementation without chlorella (Hwang et al., 2006a). This result is conflicted with the other study which reported that capacity of Cd-MT synthesis to remove Cd was increased by chlorella vulgaris (Friberg, 1984). Therefore, this may be due to an inhibition of Cd absorption by chlorella in the small intestine, resulting in declines in MT synthesis. In this study, urinary Cd excretions were increased in Cd exposed chlorella groups. Although the accurate mechanism related to this result was unknown. Based on the evidence that urinary and fecal Cd in Itai-Itai disease is excreted by chlorella intake (Hagino & Ichimura, 1975), it is thought that excretion of Cd through urine is one of the important ways of Cd removal. Thus, chlorella intake could be predicted elimination effect of Cd in human body. Urinary and serum creatinine concentrations in Cd-exposed groups were not changed compared to those in Cd-free groups in this study. However, these concentrations were slightly influenced by dietary chlorella. Renal glomerulus was not affected by Cd and dietary chlorella intake, and glomerular filtration rate (GFR) was not different among experimental groups. Therefore, it seems that Cd exposure did not exert severe renal toxicity. In summary, fecal and urinary excretions for Cd were remarkably increased in the Cd-exposed chlorella groups than in controls. Thus, Cd concentrations in tissues and blood were decreased in the Cd-exposed chlorella groups and thereby MT concentrations in organ tissues were reduced by chlorella supplementation in a dose-dependent manner. According to the results above, this study could suggest that chlorella inhibited Cd absorption, promoting the excretion of Cd from the body into feces. Also, it seems that small amount of MT was synthesized in this study due to decreased Cd absorption in the small intestine.

Notes

This work was supported by Daesang Co., Ltd. of Seoul,Korea and Brain Korea 21 project in 2007.

References
1. Andersen O, Nielsen JB, Nordberg GF. Factors affecting the intestinal uptake of cadmium from the diet. IARC Sci Publ 1992;118:173–187.
2. Berglund M, Akesson A, Bjellerup P, Vahter A. Metal-bone interaction. Toxicol Lett 2000;113:219–225.
3. Brzóska MM, Kamiński M, Supernak-Bobko D, Zwierz K, Moniuszko-Jakoniuk J. Changes in the structure and function of the kidney of rats chronically exposed to cadmium. I. Biochemical and histopathological studies. Arch Toxicol 2003;77:344–352.
4. Brzóska MM, Majewska K, Moniuszko-Jakoniuk J. Weakness in the mechanical properties of the femurs of growing female rats exposed to cadmium. Arch Toxicol 2005;79:519–530.
5. Casalino E, Calzaretti G, Sblano C, Landriscina C. Molecular inhibitory mechanisms of antioxidant enzymes in rat liver and kidney by cadmium. Toxicology 2002;179:37–50.
6. Chapman PM, Wang F, Janssen CR, Goulet RR, Kamunde CN. Conducting ecological risk assessments of inorganic metals and metalloids: Current status. Human and Ecological Risk Assessment 2003;9:641–697.
7. Cousins RJ, barber AK, Trout JR. Cadmium toxicity in growing swine. J Nutr 1973;103:964–972.
8. Dorian C, Gatto VH, Gattone 2, Klaassen CD. Accumulation and degradation of protein moiety of CdMT in the mouse kidney. Toxicol Appl Pharmacol 1992;117:242–248.
9. Eaton DL, Cherian MG. Determination of metallothionein in tissues by cadmium-hemoglobin affinity assay. Methods Enzymol 1991;205:83–88.
10. Eaton DL, Toal BF. Evaluation of the Cd/hemoglobin affinity assay for the rapid determination of metallothionein in biological tissues. Toxicol Appl Pharmacol 1982;66:134–142.
11. Elsenhans B, Strugala GJ, Schäfer SG. Small-intestinal absorption of cadmium and the significance of mucosal metallothionein. Hum Exp Toxicol 1997;16:429–434.
12. Friberg L. Cadmium and the kidney. Environ Health Perspect 1984;54:1–11.
13. Friberg L, Piscator M, Nordberg GF, Kjellstrom T. In: Cadmium in the environment. 2nd ed. OH, Cleveland. USA: CRC Press; 1974. pp. 19.
14. Goering PL, Mistry P, Fowler BA. Mechanism of metal induced cell injury. In: Haley TJ, Berndt WO, editors. Handbook of Toxicology. Washington DC. USA: Springer press; 1987. pp. 384-425.
15. Goering PL, Wıuıs MP, Klaassen CD. Toxicology of cadmium. (Handbook of Experimental Pharmacology). In: Goyer RA, Cherian MG, editors. Toxicology of Metals: Biochemical Aspects. 115. NY. USA: Springer-Verlag press; 1995. pp. 189-213.
16. Goering PT, Klaassen CD. Tolerance to cadmium-induced hepatotoxicity following cadmium pretreatment. Toxicol Appl Pharmacol 1984;74:308–313.
17. Goyer RA, Cherian MG. Renal effects of metals. In: Goyer RA, Klaassen CD, Waalkes MP, editors. Metal Toxicology. San Diego. USA: Academic Press; 1995. pp. 389-412.
18. Hagino N, Ichimura S. Effect of chlorella on fecal and urinary cadmium excretion in "Itai-itai" disease. Nippon Eiseigaku Zasshi 1975;30:77.
19. Han JG, Kang GG, Kim JK, Kim SH. The present status and future of Chlorella. Food Science Industry 2002;6:64–69.
20. Hidalgo J, Garvey JS, Armario A. On the metallothionein, glutathione and cysteinee relationship in rat liver. J Pharmacol Exp Ther 1990;255:554–564.
21. Hwang YK, Choi HJ NM, Yoo JD, Kim YH. Effect of Chlorella on Metallothionein Synthesis and Binding Capacity of Cadmium in Cadmium Poisoned Rat Liver and Kidney. J Biomed Sci 2006a;12:23–27.
22. Hwang YK, Lee YK, Yun JY, Hwang JM, Yoo JD. Effect of Chlorella on Metallothionein Synthesis and Binding Capacity of Cadmium in Cadmium Poisoned Rat Liver and Kidney. J Biomed Lab Sci 2006b;12:23–27.
23. Järup L, Berglund M, Elinder CG, Nordberg G, Vahter M. Health effects of cadmium exposure-a review of the literature and a risk estimate. Scand J Work Environ Health 1998;24:1–51.
24. Jemai H, Messaoudi I, Chaouch A, Kerkeni A. Protective effect of zinc supplementation on blood antioxidant defense system in rats exposed to cadmium. J Trace Elem Med Biol 2007;21:269–273.
25. Kägi JH, Schäffer A. Biochemistry of metallothionein. Biochemistry 1988;27:8509–8515.
26. Kagi JR, Nordberg M. In: Metallothionein, Birkhauser Verlag. Bosto, USA: Basel press; 1979. pp. 56-65.
27. Kojima M, Shishido K, Kobayashi S, Dobashi M, Ino S. A Chlorella polysaccharide as a factor stimulating RES activity. J Reticuloendothel Soc 1973;14:192–208.
28. Manuel Y, Thomas Y, Pellegrini O. Metallothionein and tissue damage. IARC Sci Publ 1992;118:231–237.
29. Min KS, Fujita Y, Onosaka S, Tanaka K. Role of intestinal metallothionein in absorption and distribution of orally administered cadmium. Toxicol Appl Pharmacol 1991;109:7–16.
30. Morita K, Matsueda T, Iida T, Hasegawa T. Chlorella Accelerates Dioxin Excretion in Rats. J Nutr 1999;129:1731–1736.
31. Nordberg GF. Application of the 'critical concentration' concept to human risk assessment for cadmium. IARC Sci Publ 1992;118:3–14.
32. Nordberg GF, Goyer R, Nordberg M. Comparative toxicity of cadmium-metallothionein and cadmium chloride on mouse kidney. Arch Pathol 1975;99:192–197.
33. Nordberg M. General aspects of cadmium: transtport, uptake and metabolism by the kidney. Environ Health Perspect 1984;54:13–20.
34. Nordberg M, Nordberg GF. On the role of metallothionein in cadmium induced renal toxicity. Experientia Suppl 1987;52:669–675.
35. Omori M, Muto Y. Effects of dietary protein, calcium, phosphorus and fiber on renal accumulation of exogenous cadmium in young rats. J Nutr Sci Vitaminol 1977;23:361–373.
36. Onosaka S, Cherian MG. Comparison of metallothionein determination by polarographic and cadmium-saturation methods. Toxicol Appl Pharmacol 1982;63:270–274.
37. Owen JK. The determination of creatinine in plasma or serum or urine: A critical examination. Biochem J 1954;58:4261–4268.
38. Park JD, Choi BS, Hong YP, Chang IW. Time-dependent pattern of cadmium (Total-, MT bound- and free-) distribution in liver and kidney. Chung-Ang Journal of Medicine 1994;19:279–291.
39. Reeves PG, Nielsen FH, Fahey GC. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993;123:1939–1951.
40. Reitman S, Frankel S. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol 1957;28:56–63.
41. Revis NW, Osborne TR. Dietary protein effects on cadmium and metallothionein accumulation in the liver and kidney of rats. Environ Health Perspect 1984;54:83–91.
42. Rikans LE, Yamano T. Mechanisms of cadmium mediated acute hepatotoxicity. J Biochem Mol Toxicol 2000;14:110–117.
43. Satarug S, Baker JR, Urbenjapol S, Haswell-Elkins M, Reilly PE, Williams DJ, Moore MR. A global perspective on cadmium pollution and toxicity in non-occupationally exposed population. Toxicol Lett 2003;137:65–83.
44. Sato M, Bremner I. Oxygen free radicals and metallothionein. Free Radic Biol Med 1993;14:325–337.
45. Shaikh ZA, Zaman K, Tang W, Vu T. Treatment of chronic cadmium nephrotoxicity by N-acetyl cysteinee. Toxicol Lett 1999;104:137–142.
46. Shim JY, Shin HS, Han JG, Park HS, Lim BL, Chung KW, Om AS. Protective effects of Chlorella vulgaris on liver toxicity in cadmium-administered rats. J Med Food 2008;11:479–485.
47. Simoni RD, Hill RL, Vaughn M. A system of blood analysis. J Biol Chem 2002;277:e9.
48. Singh A, Singh SP, Bamezai R. Inhibitory potential of Chlorella vulgaris (E-25) on mouse skin papillomagenesis and xenobiotic detoxication system. Anticancer Res 1999;19:1887–1891.
49. Thévenod F. Nephrotoxicity and the proximal tubule. insights from cadmium. Nephron Physiol 2003;93:87–93.
50. Thijssen S, Cuypers A, Maringwa J, Smeets K, Horemans N, Lambrichts I, Van Kerkhove E. Low cadmium exposure triggers a biphasic oxidative stress response in mice kidneys. Toxicology 2007;236:29–41.
51. Toraason M, Foulkes EC. Interaction between calcium and cadmium in the 1, 25-dihydroxyvitamin D3 stimulated rat duodenum. Toxicol Appl Pharmacol 1984;75:98–104.
52. Tsalev DL, Zaprianov ZK. In: Atomic Absorption Spectrometry in Occupational and Environmental Health Practice. Boca Raton, FL. USA: CRC Press; 1993. pp. 105-112.
53. Tsuritani I, Honda R, Ishizaki M, Yamada Y, Kido T, Nogawa K. Impairment of vitamin D metabolism due to environmental cadmium exposure, and possible relevance to sex-related differences in vulnerability to the bone damage. J Toxicol Environ Health 1992;37:519–533.
54. Valberg LS, Sorbie J, Hamilton DL. Gastrointestinal metabolism of cadmium in experimental iron deficiency. Am J Physiol 1976;231:462–467.
55. Wang XP, Chan HM, Goyer RA, Cherian MG. Nephrotoxicity of repeated injections of cadmium-metallothionein in rats. Toxicol Appl Pharmacol 1993;119:11–16.
56. Wilson AK, Cerny EA, Smith BD, Wagh A, Bhattacharyya MH. Effects of cadmium on osteoclast formation and activity in vitro. Toxicol Appl Pharmacol 1996;140:451–460.
57. Yeager DW, Cholak J, Henderson EW. Determination of lead in biological and related material by atomic absorption spectrophotometry. Environ Sci Technol 1971;5:1020.
58. Yoshida N, Ikeda R, Okuno T. Identification and characterization of heavy metal-resistant unicellular alga isolated from soil and its potential for phytoremediation. Bioresour Technol 2006;97:1843–1849.
59. Zinterhofer LJ, Jatlow PI, Fappiano A. Atomic absorption determination of lead in blood and urine in the presence of EDTA. J Lab Clin Med 1971;78:664–674.